Guangdong Biolight Meditech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 28, 2022 at 03:01 pm IST
Share
Guangdong Biolight Meditech Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 291.79 million compared to CNY 242.73 million a year ago. Revenue was CNY 291.79 million compared to CNY 242.73 million a year ago. Net income was CNY 13.95 million compared to CNY 24.6 million a year ago. Basic earnings per share from continuing operations was CNY 0.0844 compared to CNY 0.1684 a year ago. Diluted earnings per share from continuing operations was CNY 0.0844 compared to CNY 0.1684 a year ago.
GUANGDONG BIOLIGHT MEDITECH CO., LTD. is a China-based company principally engaged in the research, development, production and sales of medical monitoring equipment, hemodialysis products and ancillary products. Its medical monitoring equipment includes monitoring equipment, electrocardiograph, pulse oximeters and central monitoring systems. Its hemodialysis products include hemodialysis machines, hemodialyzers, hemodialysis powders/dialysates and perfusion machines. The Company distributes its products in domestic and overseas markets.